EHA 2026
Overview
The European hematology flagship — 11,000+ hematologists annually, including a strong contingent from Asia and Latin America. Best venue for oncology and benign hematology products with European or global market goals.
Key Facts
- Host organization: European Hematology Association
- Primary specialty: hematology
- Scale: large
- Geography: International
- International attendance: ~75%
Best For
Buyer Stage Fit
Booth Costs
Booth pricing not yet verified for EHA. Request our research →
All-In Cost Estimate (10×10 Inline)
| Space rental | — |
| Drayage | $1,200 – $2,500 |
| Electrical (20A) | $300 – $450 |
| Carpet/padding | $200 – $400 |
| Cleaning (3 days) | $150 – $250 |
| Lead retrieval (1 unit) | $400 – $900 |
| Wi-Fi | $500 – $1,500 |
| Estimated total | $10,000 – $20,000 |
Does not include travel, staffing, booth display, or marketing materials.
Audience
Hematologists from 100+ countries. Strong academic component — late-breaking malignant and benign hematology research.
- Purchasing authority: ~35% of attendees
- Effective buyers: ~3,850
- Cost per effective buyer: $3.9 ($15,000 all-in ÷ 3,850 buyers)
- International attendance: ~75%
Venue & Logistics
- Venue: Frankfurt, Germany (rotates across European cities)
- Management company: EHA (in-house)
- Product theater: Available
Who Else Exhibits
Approximately 100+ exhibitors typically attend EHA. Your competitors are here.
Our Take
Why Exhibit
The European hematology flagship — 11,000+ hematologists annually, including a strong contingent from Asia and Latin America. Best venue for oncology and benign hematology products with European or global market goals.
Why Skip
Skip if hematology is adjacent rather than core to your portfolio — the audience is highly specialized and won't engage with generic oncology messaging. Heavy academic skew (35% purchasing authority).
Insider Tips
EHA satellite symposia book early and are oversubscribed. Cell and gene therapy companies dominate the latest editions. KOL programs around late-breaking abstracts drive the highest qualified-meeting volume.
Buzzbox Score: 8.4 / 10 (Excellent)
8.4 out of 10. A top-tier show worth a serious line item. Carried by cost efficiency (8.9: $30/sqft, right at the dataset median). The lightest dimension is data transparency (7.6, booth pricing published). The European hematology flagship, 11,000+ hematologists annually, including a strong contingent from Asia and Latin America.
How we score
Six weighted factors, each scored on a 0 to 100 rubric then normalized to a 7.0 to 10.0 band. Every show on this list cleared a relevance bar to be included, so 7.0 is the floor; the number tells you how far the leaders pull ahead.
Strong (8.0): 35% purchasing authority (clinician-heavy), 110:1 attendee-to-exhibitor ratio, and large-scale event.
Strong (8.9): $30/sqft, right at the dataset median.
Solid (7.6): booth pricing published, exhibitor count disclosed, and attendee purchasing-authority data published.
Strong (8.7): society-run exhibits (in-house), non-union venue (simpler, cheaper move-in), and product theater / demo stage available.
Strong (8.1): "who should skip" note included, the flagship / largest show in its niche, and product-theater opportunity for thought leadership.
Strong (8.8): large and well-established and 11,000 attendees.
Key Deadlines
Detailed deadlines not yet verified for EHA. Check the official site for the application window.
Frequently Asked Questions
How much does a booth cost at EHA?
An all-in 10×10 booth at EHA runs roughly $10,000–$20,000, including space rental, drayage, electrical, carpet, and basic services. Travel, staffing, and booth display are additional.
How many people attend EHA?
EHA draws approximately 11,000 attendees. Hematologists from 100+ countries. Strong academic component — late-breaking malignant and benign hematology research.
When is EHA ?
EHA is scheduled for June 11-14, 2026. Location: Frankfurt, Germany (rotates across European cities).
Is EHA worth exhibiting at?
The European hematology flagship — 11,000+ hematologists annually, including a strong contingent from Asia and Latin America. Best venue for oncology and benign hematology products with European or global market goals..